Latest Breaking News On - Peter meintjes - Page 4 : comparemela.com

Record for lab testing throughput

Pacific Edge has posted another record quarter in laboratory testing throughput for its Cxbladder products ironically the announcement on the.

Pacific Edge given stay on US decision not to use its tests

Bladder cancer diagnostics company Pacific Edge has been handed a lifeline, after a US Medicare Provider said it would delay implementing a decision to no longer cover the company's flagship Cxbladder test.

Pacific Edge battles out proposed end of US Medicare coverage for Cxbladder tests

New Zealand company Pacific Edge (ASX: PEB) has updated its billing policies in the US for its range of Cxbladder non-invasive genomic urine tests for the detection and management of bladder cancer.

Guess which ASX healthcare share is exploding over 100% today

LCD delay welcomed by Pacific Edge

Pacific Edge has welcomed a decision to delay the implementation of the local coverage determination [LCD] that would have resulted in Medicare.